Asstrodyne TDI
company
About
Spherics engages in developing and manufacturing oral pharmaceutical products.
- 501 - 1000
Details
- Last Funding Type
- Series C
- Last Funding Money Raised
- $26.40M
- Industries
- Biopharma,Biotechnology,Manufacturing,Pharmaceutical
- Founded date
- Jan 1, 1997
- Number Of Employee
- 501 - 1000
- Operating Status
- Active
As of August 4, 2008, Spherics, Inc. went out of business. Spherics, Inc., a pharmaceutical company, engages in developing and manufacturing oral pharmaceutical products for central nervous system conditions, gastrointestinal disorders, and cancer. It develops oral systems based on the application of bioadhesive polymers to oral dosage forms. The company also provides products for neurological disorders, such as Alzheimer's, Parkinson's, and multiple sclerosis, as well as for stroke, epilepsy, chronic pain, and migraine. The company was founded in 1997 and is headquartered in Mansfield, Massachusetts.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
$36.40M
Asstrodyne TDI has raised a total of
$36.40M
in funding over 2 rounds. Their latest funding was raised on
May 13, 2005 from a Series C round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| May 13, 2005 | Series C | $26.40M | 1 |
Advent International
|
— | Detail |
| Aug 16, 2002 | Series B | $10M | 2 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
1
3
Asstrodyne TDI is funded by 3 investors.
Advent International
and POD Holding
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Advent International
|
Yes | Series C |
POD Holding
|
— | Series B |
Eastman Ventures
|
— | Series B |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
